Get started
RocketTickers

Esperion Announces FDA Approval of NEXLETOL™ (bempedoic acid) Ta

Long
Esperion Therapeutics, Inc. (NASDAQ:ESPR)  
RocketTickers  
NASDAQ:ESPR   Esperion Therapeutics, Inc.
Beyond Technical Analysis
2
0
beyondta
ESPR: Esperion Therapeutics, Inc.
2020-02-21 16:38:10
Esperion Announces FDA Approval of NEXLETOL™ (bempedoic acid) Tablet, an Oral, Once-Daily, Non-Statin LDL-Cholesterol Lowering Medicine
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.